Nanotechnology: the challenge of regulating known unknowns.
Media reports of the health hazards posed by nano-sized particles (NSPs) have turned a white hot spotlight on the risks of nanotechnology. Worried about the risks posed to workers producing nano-materials, the Washington Post has labeled nanotechnology a "seat-of-the-pants occupational health experiment." This article examines our emerging knowledge base about the hazards of two types of exposure: inhalation of NSPs and topical application of products containing NSPs. It argues that a clear-eyed evaluation of the benefits and risks of nanotechnology is made extremely difficult by the marriage of a complex science with a venture capitalist-like hype. It then suggests that, absent additional statutory authority, governmental regulators cannot readily address the risks posed by these products. This regulatory inaction leaves a significant role for the private insurance market, a role that regulators should support in tangible ways outlined in the article.
Wilson
Robin Fretwell
RF
Washington & Lee University School of Law, USA.
D030861:Capitalism; D003257:Consumer Product Safety; D033161:Government Regulation; D006801:Humans; D008402:Mass Media; D036103:Nanotechnology; D018570:Risk Assessment; D014481:United States